WuXi Biologics Stock
Detail | Data |
---|---|
Volume (24h): | 48,843,549 shares |
P/E Ratio: | 28.82 |
Forward P/E: | 23.79 |
EPS: | 0.85 HKD |
Forward EPS: | 1.03 HKD |
Number of Shares: | 4,068,679,936 shares |
Market Capitalization: | 99,682,656,256.00 HKD |
Dividend
Dividend | Value |
---|---|
Dividend Amount | According to our data, the company WuXi Biologics does not currently pay dividends. |
Annual Yield %: | - |
Ex-dividend Date: | - |
5-Year Avg Yield %: | - |
Payout Ratio: | - |
Last Dividend Value: | - |
Last Dividend Date: | - |
Analyst Forecast
Analysts | Recommendation |
---|---|
Issued Recommendation: | According to our data, the recommendation for WuXi Biologics stock is: none |
Number of Analysts: | 26 |
Highest Target Price: | 45.92349 HKD |
Lowest Target Price: | 18.319773 HKD |
Median Target Price: | 28.793447 HKD |
Fundamental Indicators
Indicator | Data |
---|---|
Total Revenue: | 18,675,369,984.00 HKD |
Net Income: | 3,356,080,896.00 HKD |
Price-to-Book (P/B): | 2.41 |
PEG Ratio: | / |
Exchange: | HKSE |
Industry: | Biotechnology |
Sector: | Healthcare |
Number of Employees: | 12575 |
Country: | China |
Where to Buy WuXi Biologics Stock?
You can purchase WuXi Biologics stock on the HKSE under the ticker symbol: 2269.HK. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.
Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.
More Information on WuXi Biologics Stock
Indicator | Value |
---|---|
Company Revenue: | 18,675,369,984.00 HKD |
EBITDA: | 5,848,817,152.00 HKD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
Earnings Per Share: | 0.85 HKD |
Book Value Per Share: | 10.19 HKD |
Total Cash: | 10,709,790,720.00 HKD |
Total Cash per Share: | 2.61 HKD |
Total Debt: | 4,939,849,216.00 HKD |
Debt to Equity Ratio: | 0.11 |
Quick Ratio | 1.98 |
Current Ratio | 2.73 |
Free Cash Flow | -2,296,172,032.00 HKD |
Operating Cash Flow | 5,217,256,960.00 HKD |
Gross Margins | 40.97 % |
EBITDA Margins | 31.32 % |
Operating Margins | 27.38 % |
Profit Margins | 17.97 % |
Return on Assets | 5.0 % |
Return on Equity | 8.8 % |
Earnings Growth (1 year) | 73.0% |
Revenue Growth (1 year) | 18.3 % |
Quarterly Earnings Year-over-Year Growth | 63.9 % |
Market Capitalization | 99,682,656,256.00 HKD |
Enterprise Value | 98,483,888,128.00 HKD |
EV/Revenue | 5.273 |
EV/EBITDA | 16.838 |
Float Shares | 3,494,440,232 shares |
Shares Outstanding | 4,068,679,936 shares |
Held Percent Insiders | 0.15 % |
Held Percent Institutions | 35.90 % |
Shares Short | - |
Shares Short Prior Month | - |
Date Short Interest | - |
Short Percentage of Total Shares | - |
Short Ratio | - |
Beta | 0.55 |
Short Percentage of Float | - |
Implied Shares Outstanding | 4,117,700,096 |
Frequently Asked Questions (FAQ)
According to our data, the company WuXi Biologics does not pay dividends yet, even in 2025.
WuXi Biologics shares are traded on the HKSE stock exchange under the ticker: 2269.HK. You can buy or trade them through a variety of stock brokers who provide real stock trading services.
According to our data, the recommendation for WuXi Biologics shares is from a total of 26 analysts. The average target price prediction is 28.793447 HKD per share.
The total number of WuXi Biologics shares on the exchange is 4,068,679,936.00 shares, which at the current market capitalization gives the company a total valuation of 99,682,656,256.00 HKD.